Tag Archives: safety

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »

OIG raises concerns about safety in long-term care hospitals

Dive Brief: Roughly one in five Medicare patients in long-term care hospitals experienced adverse events, and another 25% experienced temporary harmful events, according to a new report by the HHS Office of Inspector General (OIG). More than half (53%) of the adverse events patients suffered caused F level harm, meaning they prolonged the LTCH stay, became… Read More »